Top tips to prevent pink eye

March 20, 2024

No need for alarm over KZN outbreak

Following a recent warning by the KwaZulu-Natal Department of Health about an outbreak of pink eye in parts of the province, Netcare Medicross is assuring residents that while there is no need for alarm, understanding more about this eye condition is important to prevent spread and complications. 

 

General practitioner Dr Nishen Gounder, who practises at Netcare Medicross Malvern, explains all your family needs to know about this.

 

What is pink eye?

“Pink eye, or conjunctivitis, is the inflammation of the thin membrane, called the conjunctiva which covers the whites of the eye and the inner part of the eyelid. It can be caused by a viral or bacterial infection, an allergic reaction or environmental irritation,” Dr Gounder says.

 

“These can cause the delicate eye membrane to become red and inflamed, resulting in discomfort including itching, pain, swelling, fluid discharge and a scratchy or gritty feeling, as if there is sand in the eye,” he says.

 

“The cause of pink eye can be either viral or bacterial, both of which are highly contagious and easily spread in communities or schools through close contact and hand contamination. The public can play its part by helping to ensure pink eye does not spread further.”

 

Viral pink eye

Viral pink eye can be caused by various viruses, including the virus that causes the common cold symptoms. Pink eye is very contagious. It spreads through contact with infected secretions from the eye, and often the second eye becomes infected within 24 to 48 hours.

 

“Many people will have mild symptoms which will settle without intervention within a week or two without additional treatment. The redness, irritation and tearing usually settle first, but one may experience some morning crusting of the eyes a little longer,” he says.

 

“If one uses contact lenses, it is always important to come and see your GP if you notice symptoms to exclude other possible serious causes, like the infection of the cornea,” says Dr Gounder.

 

Bacterial pink eye

“While not as contagious as viral conjunctivitis, bacterial conjunctivitis is also highly contagious. but the symptoms differ from those of viral infection, with a yellow, white or green discharge common throughout the day. In the morning, one will wake with the eye being ‘stuck shut’ with a crust of dried discharge. An antibiotic in the form of drops or ointment, as prescribed by a GP, is needed to treat this condition effectively.” 

 

Other serious symptoms that need immediate medical attention

  • Pain and tenderness of the eye
  • Vision disturbances
  • Sensitivity to light or difficulty keeping the eye(s) open
  • Other symptoms such as severe headache with nausea

Ten top tips for preventing and treating pink eye


  1. If you suspect you or your child may have pink eye, visit your Netcare Medicross general practitioner and seek their guidance on treating the condition.
  2. Make sure your doctor provides a sick note while you wait for the pink eye discharge to stop, usually after 24 hours of antibacterial treatment.
  3. To protect yourself against pink eye infection, be strict in general hygiene practices. Remember that handwashing with soap or alcohol-based sanitising is an effective way to keep you and your loved ones safe from pink eye and many other infectious illnesses.
  4. Where possible, avoid contact with people who have pink eye. Avoid physical contact, such as shaking hands, sharing pens, phones, touch screens, and makeup.
  5. If you’re exposed to someone with pink eye, wash your hands often with soap and water and change your bedlinen daily. Don’t share facecloths, towels, or pillows.
  6. Stop using contact lenses as soon as you suspect you may have pink eye.
  7. Seek medical advice immediately if you experience severe pain, a change in your vision, any sign of pus or if you notice intense redness in your eyes.
  8. Immunocompromised patients, such as those on cancer treatment or biological agents and those living with HIV and diabetes, should seek advice from their treating doctor as early as possible.
  9. If you are diagnosed with pink eye, wash your hands often and do your best to prevent infecting those around you at home.
  10. It’s important that babies and young children see a doctor as soon as their caregiver notices symptoms of the condition.

 

To book an appointment with a Netcare Medicross Medical and Dental Centre near you, visit https://www.netcare.co.za/search?path=medicross_medical_dental or make use of the Netcare App.

Obstetrician and gynaecologist Dr Natalie Odell
March 26, 2025
The physical strain pregnancy puts on an expectant mother’s body should not be underestimated. An obstetrician gynaecologist offers her insights for alleviating discomfort and promoting wellbeing with exercise and stretching throughout pregnancy.
Dr Patience Sigwadi
March 19, 2025
Dr Patience Sigwadi, a leading paediatric nephrologist practising at Netcare Unitas Hospital in Centurion, has issued an urgent call for increased focus on skills development to address the escalating kidney disease crisis among children in South Africa.
Paediatric Nephrologist Prof Rajendra Bhimma
March 11, 2025
Paediatric Nephrologist Professor Bhimma was recently awarded the Fellowship to acknowledge his extensive work in research, community-based outreach and teaching of paediatric nephrology, among others.
Prof Bhekifa Dube
March 7, 2025
Netcare congratulates Professor Bhekifa Dube on his invitation to join the European Society for Vascular Surgery's clinical practice guidelines committee. His selection as the only specialist from the continent highlights the significance of this achievement on the global stage.
Rare Disease Day on 28 February 2025
February 28, 2025
The lives of millions of South Africans with a litany of rare diseases can be vastly improved, and even saved, by addressing challenges in identifying, studying and treating their conditions. With Rare Disease Day on the 28th of February 2025, the Rare Diseases Access Initiative (RDAI) is driving an evolution of the country’s healthcare, through innovative strategies to better care for over 4.2million people living with an estimated 7000 rare diseases. “As our healthcare system faces significant changes in the years ahead, it is vital that we also advocate for people living with rare diseases in South Africa, especially those with limited healthcare access,” said Kelly du Plessis, CEO of Rare Diseases South Africa (RDSA), a member of RDAI. “As part of our ongoing research and awareness efforts, RDAI has conducted an initial analysis of the incidence and prevalence of rare diseases within the country.” This research will assist in improving access to healthcare, policy development, and patient advocacy, while giving critical insight into the challenges faced by patients. “According to research, some rare diseases affect fewer than 1 in a million people, while others, such as Down syndrome, cystic fibrosis, and haemophilia, have a more recognisable prevalence,” says Dr. Helen Malherbe, RDAI lead researcher on rare disease prevalence data. “Many conditions are undetected, underdiagnosed or misdiagnosed, with too many having no information available about them at all.” The RDAI was formed in 2019 to promote a more favourable environment for those impacted by rare diseases in South Africa. Participants include Ampath, the Board of Healthcare Funders (BHF), Discovery Health, Genetic Counsellors South Africa (SASHG), the Government Employees Medical Scheme (GEMS), Health Funders Association (HFA), Medihelp, Medscheme, North-West University (NWU), Rare Diseases South Africa (RDSA), the South African Medical Association (SAMA) and The South African Medical Technology Industry Association (SAMED). The Council for Medical Schemes (CMS) participates as an observer. In the same year, Rare Disease International signed a memorandum of understanding with the World Health Organisation leading to an international rare disease policy framework. In 2021, the United Nations General Assembly moved to adopt a resolution recognising 300 million people living with rare diseases worldwide. “A general lack of awareness and delayed diagnosis remain major hurdles for those affected by rare diseases. Policymakers and healthcare stakeholders need to prioritise access to treatment, diagnosis, and support for rare disease patients,” says Bada Pharasi, CEO of IPASA, “Through this initiative, working collaboratively with stakeholders at every level of the healthcare supply chain, we can bring real and meaningful change to those affected, including family members and care givers, through smart and efficient strategies.” The globally agreed definition of a rare disease is any medical condition with a specific pattern of clinical signs, symptoms, and findings that affects fewer than or equal to 1 in 2000 persons in a population. “Most are genetic, and some are inherited and passed down in families,” Malherbe says. “Some affect only the patient’s genetic recipe, while others may be acquired during life due to infection, trauma, or environmental effects. For many, the cause is still unknown. “These conditions mainly affect children, as they are largely incurable and many are life-threatening. Some require specialised and co-ordinated care, some have limited and expensive treatment options, while others have no information or effective treatments at all,” she adds. The RDAI is calling for a patient-centred care model built on equitable access, transparency and efficiency. Naturally, this model calls for the open participation of patients, the healthcare industry, health professionals, and the Government. “The most critical elements are robust diagnosis standards, improved access to treatment, data collection and management, co-ordination of care, measurement of outcomes and ongoing collaborative research,” du Plessis says. “We need to establish rare disease advisory committees, map gaps and opportunities, establish system requirements, create a roadmap and plan a phased implementation with clear timelines.” The RDAI states that these policy development steps would be a start in quantifying the disease burden and defining standards of care. This would be followed by building and strengthening the capacity to facilitate appropriate diagnosis, treatment, continuity and data monitoring. Thoneshan Naidoo, Chief Executive Officer of the Health Funders Association noted that, “We appreciate the unique opportunity provided by RDAI which enables stakeholders across the industry to work together and identify strategies that improve equitable access to the appropriate diagnosis, treatment and healthcare services for rare disease patients, in an affordable and sustainable manner, taking account of the other pressing needs across the healthcare system.” “True innovation in healthcare is only possible through partnerships and joint advocacy efforts that raise awareness and improve access to treatment. Our long-term goal is the development of a rare diseases policy framework and guidelines for coordinated care,” says Pharasi. “Our members are united in the commitment to unlocking improved patient outcomes and improving access to services and robust health needs assessment facilities.” he concludes. About RDAI The Rare Diseases Access Initiative (RDAI) is dedicated to advocating for improved healthcare access, policy development, and patient support for those affected by rare diseases in South Africa. The initiative brings together key healthcare stakeholders, including pharmaceutical associations, funders, genetic specialists, and patient advocacy groups, to drive impactful change. About RDSA Founded in 2013, Rare Diseases South Africa (RDSA) is a non-profit organisation advocating to ensure that people living with rare diseases and congenital disorders experience greater recognition, support, improved health service and better overall quality of life. Started out of personal need following the diagnosis of organisation founder, Kelly du Plessis' son, it became evident that there was a lack of awareness and support for rare diseases in general in South Africa. About IPASA The Innovative Pharmaceutical Association South Africa (IPASA) is a voluntary trade association representing 24 leading pharmaceutical companies committed to research, development, and innovation. Our mission is to drive healthcare advancement by advocating for policies that improve patient access to safe, high-quality, and affordable medicines.
Gastroenterologist Dr Barbara Makumbi explains the toll acid reflux can take on your health
February 26, 2025
Gastroenterologist Dr. Barbara Makumbi discusses common risk factors and offers tips for managing reflux and the longer-term condition known as gastroesophageal reflux disease (GORD).
Netcare St Anne’s Hospital emergency department now has both trauma and emergency  specialists.
February 19, 2025
From treating trauma injuries caused by wildlife, road accidents and sports, to heart attacks, stroke, or the sudden onset of other concerning medical symptoms – the emergency department at Netcare St Anne’s Hospital never sleeps.
Making sense of self-harm
February 10, 2025
As many as one in ten teenagers may self-harm, often in secret, concealing the scars or evidence of their injuries. As Teen Suicide Prevention Week approaches, Netcare Akeso is highlighting the often-hidden struggle of self-harm among young people.
Dr Prinitha Pillay is a radiation and clinical oncologist
February 4, 2025
With one in four South Africans affected by cancer, either directly or through a loved one’s diagnosis, the importance of regular screenings cannot be overstated.
Melanoma awereness
January 27, 2025
This SunSmart Skin Cancer Awareness Month, oncologists Dr Sylvia Rodrigues and Dr Karen Motilall stress the importance of sun protection and regular screening for melanoma in South Africa's sunny climate.
More Posts
Share by: